Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | CASP6 | P55212 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23937834 | 0.84 | — | — | |
| SCHEMBL23937899 | 0.79 | HSD17B10 (0.33) | KDM4ECASP1CASP7 | |
| SCHEMBL20631142 | 0.79 | KDM4E (0.33) | MAPK1KDM4ECASP1CASP7 | |
| SCHEMBL23937917 | 0.78 | HSD17B10 (0.35) | MAPK1KDM4EMAPTCASP1CASP7 | |
| SCHEMBL21959626 | 0.70 | PARP1 (0.33) | KDM4EHTT | |
| SCHEMBL20631714 | 0.70 | GRM2 (0.32) | GRM2 | |
| SCHEMBL21959624 | 0.70 | KAT2B (0.38) | HTT | |
| SCHEMBL18548378 | 0.67 | MAPK1 (0.33) | MAPK1KDM4ENSD2LMNAMAPT | |
| SCHEMBL20631706 | 0.67 | GAA (0.33) | — | |
| SCHEMBL23937926 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3399968-B1 | SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE | CS PHARMATECH LTD (KY) | 2021-10-20 | — | — | EP | disclosed |